Back Technical Analysis

(A) Most Important Chart

Published on March 17, 2024

∙ Download the PDF Report

By

John Roque

Chart Watchers – Before getting into today’s note, please check your Outlook inboxes for an invitation to my Webinar on Tuesday, March 19, 2024, at 10:30am. It’ll be a chart-apalooza good time with loads of charts, cheeky commentary, some cultural touchstones and, as has become a tradition, the 22V Technical Webinar Book Giveaway. Here’s the link to the Webinar: Webinar Registration – Zoom. See you on Tuesday.

In Blasphemous Rumors on March 12, 2024, I presented the idea that we were are at the juncture where Non-Growth would start to gain ground / outperform vs. Growth. Here were are my thoughts:

A graph of stock market growth

Description automatically generated with medium confidenceThe weekly chart above shows my Growth / Non-Growth Ratio which is two ETFs in the numerator (XLK + XLY) divided by four ETFs in the denominator (XLB + XLE + XLF + XLI) with a corresponding MACD momentum indicator.

1 The Jan ‘23 – Feb ’24 outperformance rally for Growth over Non-Growth was +42% over 57 weeks which is not that different, when adjusted for length of advance, with what happened when the ratio gained 23% over 27 weeks from May ’21 – November ’21.

2 In this part of the cycle MACD momentum peaked in July ’23 well ahead of the now obvious lower high in MACD momentum which occurred in February ’24 (see LH for Lower High in the bottom panel). What’s occurring now is not an identical replay to what was seen in 2020, but MACD momentum peaked five months before price did (May ’20 vs. Oct ’20) and this time MACD momentum peaked seven months ago (July ’23 vs. Feb ’24).

3 In the 20 now 21 weeks since the S&P’s low / market’s turn from October 27, 2023, while the Growth component of my ratio added 28% 23 and beat the Non-Growth component’s 20%, both Growth has won 10X and Non-Growth has now won 11X. have each won in the weekly competition 10X. So, while Growth gets all the attention (rightfully so given 800bp of outperformance over 20 weeks), Growth is now only beating Non-Growth by 300bps. Further, Non-Growth deserves more respect than it gets / has gotten given that it is tied Growth for the now leading Growth in the number of weekly wins. To make matters more interesting, Non-Growth has beaten Growth in 9 of 15 10 of 16 weeks from Dec 1, 2023 – Mar 15, 2024, and the relative ratio between the two has moved lower by 4 ½% in favor of Non-Growth. is flat over this time frame. This is the reason a lower high has developed in the MACD telling us of the change in momentum from Growth to Non-Growth.

4 The loss in momentum for Growth might simply be explained via the Big Chasm among the Big 7 / Magnificent 7. The following chart appears in my weekly chart packets / Webinar chart packets / presentation chart packets and makes clear that price action for these Big 7 stocks is no longer monolithic.

A graph of stock market prices

Description automatically generated with medium confidence

To emphasize the change occurring for Non-Growth to outperform Growth consider that Non-Growth has beaten Growth in four of the last five weeks and since the Feb 9, 2024, peak in the Growth to Non-Growth Ratio (chart at top), the ratio is down by 7 ½% in favor of Non-Growth.

Growth Index – Weekly – Tech (XLK) + Consumer Disc (XLY) w/ 40-Week MA, Weekly MACD and Growth Relative to S&P 500. While the chart in the top panel is still healthy holding at / just above its breakout level, the momentum indicator in the middle panel is (a) overbought and is (b) overbought in an area where Growth peaked in late 2021 (-38% over 58 weeks) and corrected in 2023 (-11% over 13 weeks). And, perhaps more importantly, the bottom panel shows Growth Relative to the S&P 500 is topping with this relative ratio at its lowest level in 21 weeks (!) and is no different than it was in July 2020!

A graph of stock market growth

Description automatically generated with medium confidence

Non-Growth Index – Weekly – Energy (XLE) + Financials (XLF) + Industrials (XLI) + Materials (XLB) w/ 40-Week MA, Weekly MACD and Growth Relative to S&P 500. The chart in the top panel is in an encouraging position – notice the BASE & Breakout – and has gained for 8 weeks in a row adding 10% in the process. The MACD momentum indicator in the middle panel is still pushing higher. Non-Growth Relative to the S&P, in the bottom panel, is up 4% since the week ending Feb 9, 2024.

A screenshot of a graph

Description automatically generated

This chart is the same chart that appears at the top of this note, and this is a good time to emphasize the following: The Growth / Non-Growth Ratio has a Technical Score = 2, Neutral, down from a Technical Score = 3, Good, from one week ago. Recent performance figures for this Ratio look like this on a 1-day (-1.35%), 5-day (-2.39%), 1 month (-4.34%) and a 3-month (-4.15%) basis. And, on a 6 Month basis the Ratio is only up 2.3%. In short, Growth has lost momentum versus Non-Growth and, as the MACD in the lower panel shows, is not oversold. I’m going to keep looking for Non-Growth to outperform Growth until the MACD in the lower panel gets oversold, bottoms, and turns upward.

A graph of stock market growth

Description automatically generated with medium confidence

DISCLOSURES AND DISCLAIMERS

Analyst Certification

The analyst, 22V Research Group, primarily responsible for the preparation of this research report attests to the following: (1) that the views and opinions rendered in this research report reflect his or her personal views about the subject companies or issuers; and (2) that no part of the research analyst’s compensation was, is, or will be directly related to the specific recommendations or views in this research report.

Analyst Certifications and Independence of Research.

Each of the 22V Research analysts whose names appear on the front page of this report hereby certify that all the views expressed in this Report accurately reflect our personal views about any and all of the subject securities or issuers and that no part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views of in this Report.

22V Research (the “Company”) is an independent research provider. The Company is not a member of the FINRA or the SIPC and is not a registered broker dealer or investment adviser. 22V Research has no other regulated or unregulated business activities which conflict with its provision of independent research.

22V Research, LLC is a professional services and independent publication organization. 22V Research, LLC is not a securities broker-dealer, not a member of the Financial Industry Regulatory Authority (FINRA), not a registered investment advisor (RIA) and not a member of SIPC.

Securities transactions, when offered, are offered by 22V Securities, LLC through LPS Capital, LLC. Certain employees of 22V Securities, LLC are dually registered as securities representatives of LPS Capital, LLC or Analyst Hub Securities, LLC. 22V Securities, LPS Capital and Analyst Hub Securities are members FINRA, SIPC.

https://brokercheck.finra.org/

Current Ratings Definition.

SECTOR OUTPERFORM: An “outperform” rating anticipates the company will outperform the S&P Regional Banking Index (peer group).

SECTOR PERFORM: A “market perform” rating anticipates the company will perform in line with the S&P Regional Banking Index (peer group).

SECTOR UNDERPERFORM: An “underperform” rating anticipates the company will underperform the S&P Regional Banking Index (peer group).

Limitation Of Research And Information.

This Report has been prepared for distribution to only qualified institutional or professional clients of 22V Research Group. The contents of this Report represent the views, opinions, and analyses of its authors. The information contained herein does not constitute financial, legal, tax or any other advice. All third-party data presented herein were obtained from publicly available sources which are believed to be reliable; however, the Company makes no warranty, express or implied, concerning the accuracy or completeness of such information. In no event shall the Company be responsible or liable for the correctness of, or update to, any such material or for any damage or lost opportunities resulting from use of this data. Nothing contained in this Report or any distribution by the Company should be construed as any offer to sell, or any solicitation of an offer to buy, any security or investment. Any research or other material received should not be construed as individualized investment advice. Investment decisions should be made as part of an overall portfolio strategy and you should consult with a professional financial advisor, legal and tax advisor prior to making any investment decision. 22V Research Group shall not be liable for any direct or indirect, incidental or consequential loss or damage (including loss of profits, revenue or goodwill) arising from any investment decisions based on information or research obtained from 22V Research Group.

Reproduction And Distribution Strictly Prohibited.

No user of this Report may reproduce, modify, copy, distribute, sell, resell, transmit, transfer, license, assign or publish the Report itself or any information contained therein. Notwithstanding the foregoing, clients with access to working models are permitted to alter or modify the information contained therein, provided that it is solely for such client’s own use. This Report is not intended to be available or distributed for any purpose that would be deemed unlawful or otherwise prohibited by any local, state, national or international laws or regulations or would otherwise subject the Company to registration or regulation of any kind within such jurisdiction.

Copyrights, Trademarks, Intellectual Property.

22V Research Group, and any logos or marks included in this Report are proprietary materials. The use of such terms and logos and marks without the express written consent of 22V Research Group is strictly prohibited. The copyright in the pages or in the screens of the Report, and in the information and material therein, is proprietary material owned by 22V Research Group unless otherwise indicated. The unauthorized use of any material on this Report may violate numerous statutes, regulations and laws, including, but not limited to, copyright, trademark, trade secret or patent laws.